Abstract-Cardiac hypertrophy is associated with alterations in cardiomyocyte excitation-contraction coupling (ECC) and Ca 2ϩ handling. Chronic elevation of plasma angiotensin II (Ang II) is a major determinant in the pathogenesis of cardiac hypertrophy and congestive heart failure. However, the molecular mechanisms by which the direct actions of Ang II on cardiomyocytes contribute to ECC remodeling are not precisely known. This question was addressed using cardiac myocytes isolated from transgenic (TG1306/1R [TG]) mice exhibiting cardiac specific overexpression of angiotensinogen, which develop Ang II-mediated cardiac hypertrophy in the absence of hemodynamic overload. Electrophysiological techniques, photolysis of caged Ca 2ϩ and confocal Ca 2ϩ imaging were used to examine ECC remodeling at early (Ϸ20 weeks of age) and late (Ϸ60 weeks of age) time points during the development of cardiac dysfunction. In young TG mice, increased cardiac Ang II levels induced a hypertrophic response in cardiomyocyte, which was accompanied by an adaptive change of Ca 2ϩ signaling, specifically an upregulation of the Na ϩ /Ca 2ϩ exchangermediated Ca 2ϩ transport. In contrast, maladaptation was evident in older TG mice, as suggested by reduced sarcoplasmic reticulum Ca 2ϩ content resulting from a shift in the ratio of plasmalemmal Ca 2ϩ removal and sarcoplasmic reticulum Ca 2ϩ uptake. This was associated with a conserved ECC gain, consistent with a state of hypersensitivity in Ca 2ϩ -induced Ca 2ϩ release. Together, our data suggest that chronic elevation of cardiac Ang II levels significantly alters cardiomyocyte ECC in the long term, and thereby contractility, independently of hemodynamic overload and arterial hypertension. Key Words: cardiac excitation-contraction coupling Ⅲ remodeling Ⅲ sodium-calcium exchange Ⅲ angiotensin II Ⅲ hypertrophy H ypertension is a major risk factor for the genesis and progression of a variety of cardiovascular diseases including heart failure, stroke, and kidney dysfunction. Common therapies for the treatment of hypertension lower blood pressure via inhibition of the renin-angiotensin system (RAS). Drugs include inhibitors of the angiotensinconverting enzyme, as well as angiotensin II (Ang II) receptor type 1 (AT 1 ) antagonists, thus preventing the formation of Ang II or its binding to AT 1 receptors. 1,2 In addition to its effects on the vasculature, the RAS plays an important role in the development of cardiac hypertrophy. 3 Sustained activation of the RAS results in arterial hypertension, which in turn produces hemodynamic overload. The adaptation of the heart to this loading is characterized by a change in cardiac protein expression and substantial cardiac remodeling. In addition, Ang II also exerts direct growth-promoting effects on cardiac tissues, resulting in cardiomyocyte hypertrophy and mechanical dysfunction independently of hypertension. 4,5 Ang II activates several intracellular signal transduction pathways including mitogen-activated protein kinases and protein kinase C. 6,7 Therefore, a local increase in the Ang II concentration can contribute significantly to the pathogenesis of cardiac hypertrophy, even in the absence of arterial hypertension. 8 Cardiomyocyte excitation-contraction coupling (ECC) signaling proteins have been found to be differently altered in various forms of hypertrophy. [13] [14] [15] [16] Despite their potential importance, the effects of chronically elevated levels of intracardiac Ang II on ECC remodeling and Ca 2ϩ signaling during development of hypertrophy and congestive heart failure have not been investigated.
H ypertension is a major risk factor for the genesis and progression of a variety of cardiovascular diseases including heart failure, stroke, and kidney dysfunction. Common therapies for the treatment of hypertension lower blood pressure via inhibition of the renin-angiotensin system (RAS). Drugs include inhibitors of the angiotensinconverting enzyme, as well as angiotensin II (Ang II) receptor type 1 (AT 1 ) antagonists, thus preventing the formation of Ang II or its binding to AT 1 receptors. 1, 2 In addition to its effects on the vasculature, the RAS plays an important role in the development of cardiac hypertrophy. 3 Sustained activation of the RAS results in arterial hypertension, which in turn produces hemodynamic overload. The adaptation of the heart to this loading is characterized by a change in cardiac protein expression and substantial cardiac remodeling. In addition, Ang II also exerts direct growth-promoting effects on cardiac tissues, resulting in cardiomyocyte hypertrophy and mechanical dysfunction independently of hypertension. 4, 5 Ang II activates several intracellular signal transduction pathways including mitogen-activated protein kinases and protein kinase C. 6, 7 Therefore, a local increase in the Ang II concentration can contribute significantly to the pathogenesis of cardiac hypertrophy, even in the absence of arterial hypertension. 8 Cardiomyocyte excitation-contraction coupling (ECC) sparks), the building block of the global Ca 2ϩ transients. Cardiac hypertrophy is often associated with alterations in ECC and Ca 2ϩ handling. 9 -11 However, the precise molecular mechanisms and the temporal aspects of shifts in Ca 2ϩ homeostasis are not well understood and may depend on the initial cause of the hypertrophic response. 12 Supporting this notion, the expression levels and the function of several Ca 2ϩ signaling proteins have been found to be differently altered in various forms of hypertrophy. [13] [14] [15] [16] Despite their potential importance, the effects of chronically elevated levels of intracardiac Ang II on ECC remodeling and Ca 2ϩ signaling during development of hypertrophy and congestive heart failure have not been investigated.
In the present study, we examined the role of Ang II in the remodeling of cardiac ECC using the TG1306/1R transgenic (TG) mouse model. TG mice carry multiple copies of the rat angiotensinogen gene under control of the cardiac-specific ␣-myosin heavy chain promoter, leading to elevated cardiac angiotensinogen levels. As a consequence, Ang II concentrations in the heart of TG mice are increased whereas plasma Ang II level, and therefore blood pressure, remain unchanged. Thus, the mice develop Ang II-mediated cardiac hypertrophy in the absence of high blood pressure. 8 We have previously shown that young TG mice Ϸ20 weeks of age have preserved systolic function whereas old TG mice Ϸ60 weeks of age develop cardiomyopathy characterized by diastolic and systolic dysfunction, with a major proportion of animals also developing cardiac dilation and arrhythmias. 5, 18 We have used the TG model to interrogate the temporal impacts of chronic endogenous Ang II overproduction on cardiac Ca 2ϩ signaling. We show that at early stages of disease development, increased cardiac Ang II levels induce a hypertrophic response in cardiomyocytes, accompanied by an adaptive change in Ca 2ϩ signaling involving upregulation of the Na ϩ /Ca 2ϩ exchange (NCX)-mediated Ca 2ϩ transport. In contrast, at a later stage, maladaptation is evident, where the adaptive changes resulted in a damaging outcome. This is characterized by a diminished rate of NCX-mediated Ca 2ϩ transport and reduced SR-Ca 2ϩ content attributable to shifts in the ratio in NCX and SERCA2a function. Because ECC gain is conserved in this maladaptive situation, it suggests that a state of hypersensitivity in cardiomyocyte CICR develops at a late stage of the disease and may represent a primary ECC lesion in the progression to heart failure.
Materials and Methods
The TG1306/1R mouse line used for this study has been previously described. 4, 8, 17 Mice (male) were studied at Ϸ20 weeks (young TG mice) and 60 weeks of age (old TG mice). All animal-handling procedures were performed with permission of the State Veterinary Administration and in accordance with the guidelines of the Swiss Animal Protection law. Cardiac ventricular myocytes were isolated from wild-type (WT) and TG mice using established enzymatic procedures. 18 ECC machinery was studied in acute myocyte preparations or permeabilized cells using confocal microscopy in combination with or without UV flash photolysis of caged Ca 2ϩ and I NCX and I Ca-L measurements in the whole-cell configuration of the patch-clamp technique as previously described. 19 In addition, protein expression was measured by Western blotting and mRNA expression levels were assessed by real-time PCR. An expanded Materials and Method section is available in the Online Data Supplement at http://circres.ahajournals.org.
Data were reported as meansϮSEM. Student's unpaired t test was applied to test for significance (PϽ0.01 or PϽ0.05, as indicated in the figure legends). For mRNA data, 1-way ANOVA t test was used to test for significance.
Results

Phenotype in Young TG Mice: Calcium Currents and Excitation-Contraction Coupling Gain
As previously reported, young TG mice demonstrated significant cardiac and cardiomyocyte hypertrophy Ϸ20 weeks of age. 4 Indeed, cell surface and morphological parameters indirectly measured by membrane cell capacitance (C m ), were significantly increased (Ϸ30%) in TG myocytes, indicating that myocytes isolated from the left ventricular wall showed hypertrophy (Online Table I ). In addition, the average calculated myocyte volume was increased significantly in TG animals (see Online Tables I and II (Figure 1b) . In 20-week-old TG mice, I Ca-L was increased when compared to WT cells (Figure 1a and 1b) . Because several studies reported reduced ECC gain in hypertrophied cardiomyocytes, which could affect contractile function, ECC gain was examined in the range from Ϫ20 to ϩ60 mV. 11 A loading protocol of 6 prepulses from Ϫ40 mV to ϩ10 mV for 200 ms was applied before each test pulse to ensure comparable SR-Ca 2ϩ loading conditions. In young TG mice, the ECC gain was reduced slightly, and the magnitude of this effect likely to be of little biological significance. (Figure 1b) . Using a Ca 2ϩ loading protocol, the SR-Ca 2ϩ content was estimated by rapid application of 20 mmol/L caffeine and integration of the elicited NCX current (I NCX ) (Figure 2a ). Peak I NCX was reduced in TG myocytes by Ϸ27%, whereas SR-Ca 2ϩ content was reduced by Ϸ19% (Figure 2c ). In addition, caffeine-induced Ca 2ϩ transients were diminished to a similar extent ( Figure  2b and 2c) . Western blotting demonstrated a Ϸ50% decrease in SERCA2a protein expression in the heart of young TG mice when compared to age-matched WT littermates ( Figure  2d ). Properties of spontaneous Ca 2ϩ sparks, such as frequency and amplitude, were not significantly altered in saponin-permeabilized TG cells (Figure 2e and 2f) . The Ca 2ϩ spark amplitude is, at least in part, determined by the SR-Ca 2ϩ content. The latter was measured by applying 20 mmol/L caffeine to permeabilized myocytes in the presence of 50 nmol/L free [Ca 2ϩ ]. In contrast to whole-cell conditions, myocytes isolated from young TG mice showed no significant difference in SR-Ca 2ϩ content when compared to cells from age-matched WT mice in this setting (Figure 2f ). Gene expression analysis investigated by real-time PCR showed an Ϸ5-fold upregulation of the NCX1.1 in the hearts of 20-week-old TG mice compared with age-matched WT (Figure 4d ), suggesting that the larger NCX current was associated with an increase in transporter gene expression. Finally, Figure 5a shows a plot of normalized I NCX versus Ca 2ϩ transport rate and confirms that TG myocytes generate more current per reduction of [Ca 2ϩ ] i . Ion transport capability of the NCX is estimated by the I NCX /voltage relationship, which was found to be indistinguishable between TG and WT myocytes ( Figure 5b ). Importantly, comparison of cell volume and cell membrane capacitance indicated a smaller surface-to-volume ratio in TG myocytes than in WT cells (Online Table II ). 
Phenotype in
Phenotype in Old TG Mice: Differences and Similarities in ECC Compared to WT
We have previously reported that 60-week-old TG animals exhibit systolic and diastolic dysfunction. A large proportion (Ϸ40%) of these mice demonstrate dilated cardiomyopathy. 4 Furthermore, contractile ECC latency in isolated TG cardiomyocytes is increased. 4 Our present data revealed that membrane capacitance (C m ) in old TG mice was significantly increased when compared to WT mice (Online Table II ). The average calculated myocyte volume was increased by Ϸ24% in TG myocytes. Interestingly, in contrast to what was seen in 20-week-old TG mice, the surface-to-volume ratio in myocytes isolated from 60-week-old TG mice was similar to WT despite substantial cellular hypertrophy.
Moreover, central elements of the ECC machinery, specifically I Ca-L and ECC gain, were unaltered in older TG mice (Figure 6a and 6b) . Under whole-cell conditions, using a loading protocol (Figure 7a ), caffeine-induced Ca 2ϩ transients were reduced by Ϸ30% (Figure 7a and 7b). SERCA2a protein levels were also measured in old TG hearts (Figure 7c ). Contrasting with observations in younger animals, there was no difference in total SERCA2a protein levels between WT and TG mice at 60 weeks of age. Thus, in WT, an age-dependent downregulation of SERCA2a occurred which was not seen in the TG hearts. In the TG SERCA2a levels were already low at 20 weeks and did not further reduce at 60 weeks. In skinned myocytes, spontaneous Ca 2ϩ spark frequency as well as the SR-Ca 2ϩ content were not different between 60-week-old TG and WT mice. However, the Ca 2ϩ spark amplitude was increased (Figure 7d and 7e) .
Interestingly, I NCX (normalized to the Ca 2ϩ transient and C m ) was decreased by 40% in cardiomyocytes isolated from older TG mice when compared to age-matched WT ( Figure  8a through 8c) . In contrast to the group of young TG mice, Ca 2ϩ transport rate was also reduced by 40% in myocytes from 60-week-old TG mice (Figure 8c ). Importantly, there was no difference in cardiac NCX1 mRNA expression between old TG mice and aged-matched WT mice. However, a comparison of NCX expression between young and older TG mice suggests that aging is accompanied by downregulation of NCX gene expression in TG mice (Figure 8d versus Figure 4d ). This decreased age-dependent NCX gene expression in TG animals is not observed in WT mice and effectively normalizes NCX expression levels in old TG mice to levels measured in WT animals.
Discussion
During the development of myocardial diseases, variable shifts in Ca 2ϩ signaling have been reported in stressed cardiomyocytes. 14 -16 This adaptive response depends on multiple factors, many of which are not yet known. [21] [22] [23] [24] It is generally accepted, however, that altered function of RyRs and CICR, RyR-mediated Ca 2ϩ leak, deficient EC coupling, and/or changes in NCX and SERCA2 expression and activity can contribute to impaired myocyte contractility. 11, 14, 15, 24 To gain insight into these complex interactions, we undertook a comprehensive investigation of cardiomyocyte Ca 2ϩ signaling at 2 different time points during the development of cardiac hypertrophy and failure. 10 For this purpose, we used transgenic TG1306/1R mice, demonstrating Ang II-mediated cardiac hypertrophy and a gradual transition to heart failure.
Chronic elevation of cardiac Ang II in TG mice induces cardiac hypertrophy in the absence of high blood pressure. The hypertrophy that is observed in young animals evolves into heart failure with aging. Ultimately, the heart of TG animals is characterized by decreased contractility, slowed relaxation, and arrhythmias. 4, 25 In our study, ECC changes observed during the early stages of Ang II-induced cardiac growth may be interpreted as compensatory or adaptive, 
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whereas maladaptive ECC remodeling was seen to predominate in the more advanced stages of cardiomyocyte and cardiac dysfunction. We propose that a shift in the ratio of SR-Ca 2ϩ removal and reuptake (resulting from reduced SERCA2a and NCX expression) is primarily responsible for myocyte dysfunction in older TG cardiomyocytes. Our findings also indicate that higher Ca 2ϩ sensitivity of the SR-Ca 2ϩ release mechanism may partly compensate for the diminished SR-Ca 2ϩ reuptake and content. Our data emphasize the importance of aging and disease progression on ECC dysfunction and subsequent functional decompensation at the organ level.
Compensatory ECC Remodeling in Young TG Myocytes
Our findings show that, at the cellular level, central elements of ECC, such as gain (Ca 2ϩ transient to current ratio) and NCX-mediated Ca 2ϩ transport, are conserved in young TG myocytes. ECC is very robust with a high degree of "safety," and therefore it is not surprising that various compensatory mechanisms, including sensitivity of SR-Ca 2ϩ release and upregulation of NCX expression, are recruited to preserve ECC even under pathophysiological conditions. This study confirms our previous findings and shows that SERCA2a expression level is reduced in 20-week-old TG mice (Figure 2 ). 4 In intact active cells, the SR-Ca 2ϩ content is primarily determined by the SERCA2a activity and I Ca-L . It is thus expected that a reduced functional expression of SERCA2a would lead to slower SR-Ca 2ϩ reuptake and to lower end-diastolic SR-Ca 2ϩ content, associated with reduced ECC gain. 11 To maintain macroscopic ECC gain and function, Ca 2ϩ sensitivity of the SR-Ca 2ϩ release may have increased in TG mice to compensate for a reduction in SR-Ca 2ϩ content. 26 Interestingly, chronically elevated cardiac Ang II levels have been reported to accelerate the onset of ECC remodeling that normally occurs during aging via generation of reactive oxygen species. 27 In contrast, in skinned myocytes under steady resting Ca 2ϩ conditions the SR-Ca 2ϩ content is mainly balanced by the open probability of RyRs (ie, the SR-Ca 2ϩ leak), the intra-SR-Ca 2ϩ buffer conditions, and less by the rate of SR refilling by the SERCA2a. 28 If the SR-Ca 2ϩ leak is not changed appreciably, the reduced functional expression of SERCA2a may not have dramatic consequences for the SR-Ca 2ϩ content in the steady state (as is the state seen in Figure 2f ). The appearance of spontaneous Ca 2ϩ sparks is an indirect measure of the SR-Ca 2ϩ leak. Indeed, spontaneous Ca 2ϩ release events were found to be unaffected during the development of the cardiac disease phenotype in young TG myocytes, suggesting that defects of RyR function may not contribute to the Ang II-mediated phenotype.
In young TG myocytes, we observed increased I NCX density and upregulation of NCX mRNA levels. It could be expected that alterations of NCX expression and/or faster ion cycling (eg, by allosteric NCX regulation) would inevitably result in a concomitant change of NCX current and Ca 2ϩ transport rate. However, in TG myocytes increased I NCX density and NCX expression levels do not cause any change in Ca 2ϩ transport rate. We hypothesize that this discrepancy could be explained by variations in cell morphology observed in hypertrophic TG cardiomyocytes. Among cells of different sizes, I NCX can only be directly compared with the Ca 2ϩ transport when the surface-to-volume relationship remains unchanged. The reason is that I NCX changes with the surface of the cell, whereas the rate of NCX dependent decay of free [Ca 2ϩ ] i is "intrinsically" cell volume-dependent. 29 Indeed, diminished surface-to-volume ratio was observed in cardiomyocytes of young TG hearts, and this may explain why Ca 2ϩ transport rate and I NCX density are not modified in parallel. Correcting I NCX for the cell volume, normalized I NCX remained essentially unchanged. Based on the maintained Ca 2ϩ transport rate, we reason that the upregulation of I NCX via increased functional expression of NCX molecules occurred as a myocyte effort to compensate for cellular enlargement; that is, an upregulated I NCX moves the same amount of Ca 2ϩ per cell volume. Thus, the early upregulation of the NCX is possibly an adaptive process, which later has secondary and undesirable consequences.
Maladaptive ECC Remodeling in Older TG Myocytes
As previously reported, the older TG phenotype is associated with arrhythmias, changes in potassium I K1 currents, long QT syndrome, and decreases in inotropy, all hallmarks of progression to heart failure. 4 reuptake. This is supported again by the finding of an accelerated age-dependent decreased functional expression of the SERCA2a. 4 In such a dynamic scenario, a secondary downregulation of NCX function is expected to protect SR-Ca 2ϩ content, a finding that was indeed confirmed in older TG cardiomyocytes. However, the NCX downregulation does not completely offset the SR loading effect of SERCA2a activity loss. A new steady state would be achieved very gradually by a beat to beat transition, otherwise rapid net loss of SR-Ca 2ϩ would have fatal consequences. At this later stage, a reduced SR-Ca 2ϩ content could also be partly beneficial, because an increased SR-Ca 2ϩ load might be expected to have undesirable arrhythmogenic side effects. Thus, the reduced SR-Ca 2ϩ content may allow maintenance of myocyte contraction for an extended period, albeit in the context of a smaller global systolic Ca 2ϩ transient. The finding that even under conditions of low SR-Ca 2ϩ content the ECC gain remained nearly unchanged was surprising. To explain this finding, we hypothesize that the SR-Ca 2ϩ release may be more sensitive to the Ca 2ϩ trigger, suggesting Ca 2ϩ "hypersensitivity" of RyRs. 30, 31 Supporting evidence for sensitized RyRs comes from the observation of increased Ca 2ϩ spark amplitude. However, our data do not exclude the possibility that other targets in addition to the RyRs contribute to the maintained ECC gain in the Ang II-induced hypertrophic phenotype. RyR functional alteration may involve several mechanisms including reactive oxygen species modification or change in the phosphorylation state. 32, 33 The elevated Ca 2ϩ sensitivity of the RyRs and of the ECC mechanism may constitute an important mechanism which compensates for the reduced SR-Ca 2ϩ content to maintain myocyte contraction even with heart failure progression. Over the long term, the deficit in the global systolic Ca 2ϩ transient based on progressively reduced SR-Ca 2ϩ content cannot be adequately compensated for by adaptational changes in Ca 2ϩ handling, leading to a final ECC maladaptive remodeling and demise. Further investigation of Ca 2ϩ fluxes and transients in the working myocyte/myocardium will assist in developing an understanding of how Ca 2ϩ handling is altered under loaded conditions during the transition from adaptation to maladaptation.
Significance and Limitations of the Model
Management of heart failure with left ventricular hypertrophy and diastolic and/or systolic dysfunction in humans is achieved by the use of different agents including angiotensin-converting enzyme inhibitors and AT 1 receptor blockers. 34, 35 The benefit of renin-angiotensin inhibition in heart failure has been demonstrated in several randomized clinical trials. We have previously shown that the hypertrophy in the TG mice can be reversed by pharmacological suppression of the RAS, and future studies are required to determine whether reversal of ECC remodeling can be achieved by these means. 9, 36 The question of whether ECC adaptation/maladaptation and cardiomyocyte hypertrophy are separate or interdependent phenomena arises and cannot be directly resolved by the present findings. Distinct "pathological" (G␣q signaling mediated) 37 and "physiological" (phosphatidylinositol 3-kinase/Akt signaling-mediated) hypertrophic states have been characterized, and there is evidence of complex cross talk between these 2 signaling pathways. Although a systematic understanding of ECC adaptation patterns associated with different hypertrophic conditions is yet to emerge, altered Ca 2ϩ homeostasis is a central, albeit variable, phenotype. 38 The TG mouse model offers a useful and clinically relevant model of hypertrophic cardiomyopathy, recapitulating a common clinical scenario where concentric, compensated hypertrophy ultimately decompensates with dilation and transition to arrhythmogenic failure associated with premature mortality. 5, 21 The temporal pattern of altered Ca 2ϩ handling described in this study may be distinctive of an Ang II-G␣q pathology in the nonhypertensive setting. Cardiac Ang II levels increase in conditions of volume overload and in the postinfarct heart. 39 A correlation between endogenous Ang II levels and heart size has been observed in young normotensives, suggesting a link between chronic elevation of local Ang II production and cardiac pathophysiology. 40 However, one must keep in mind that the present data were obtained from isolated cells and that Ca 2ϩ signaling in vivo is also modulated by many factors, such as mechanical loading conditions and neurohumoral signals. In the in vivo situation, cardiomyocyte hypertrophy, senescence and cell death, fibroblast proliferation, and increased fibrosis produce heterogeneity in electric conduction. Ang II is also reported to modify gap junction properties and to alter cell-to-cell communication in the damaged heart. Finally, Ang II can induce ion channel remodeling and change Ca 2ϩ influx. Blockade of the RAS may, therefore, offer therapeutic benefits against electric remodeling. Experimental antiarrhythmic agents for atrial and ventricular fibrillation include angiotensin-converting enzyme inhibitors and angiotensin type I receptor blockers. In this regard, the present study supports an important role for Ang II in the regulation of Ca 2ϩ -handling protein expression and activity and suggests that enhancement of cardiac contractility might be achieved by modulating cardiomyocyte Ang II signaling.
Online supplement:
Transgenic animals, cell isolation. In brief, mice were heparinized (50 U ip), killed by cervical dislocation and the excised hearts were mounted on a Langendorff perfusion system. After perfusion with nominally Ca 2+ -free Tyrode's solution for 3-5 minutes, at 37 o C, collagenase II (14 U/ml, Worthington type 2), protease (0.2 U/ml, Sigma, type XIV). After additional 6-9 minutes of perfusion, hearts were removed from the Langendorff apparatus and the ventricles were cut in small pieces, followed by gentle trituration to obtain a cell suspension. Subsequently, the Ca 2+ concentration was slowly raised (over 60 minutes) to measurements were recorded in the whole-cell configuration using patch-clamp technique as previously Biotechnologies), nitrocellulose membranes were incubated with diluted primary antibodies (1:1000) for 2 hours at room temperature. After 3 series of washing (1xPBS in 1% skim milk), blots were incubated with peroxidase-conjugated (HRP) secondary antibodies and bands were revealed using the ECL PCR products as they accumulate during PCR. Two distinct TaqMan Gene Expression Assays, containing a specific probe and primer pairs, were ordered for the amplification of the NCX1 (Slc8a1): The I NCX activation via photorelease of "caged" Ca 2+ is the methodology of choice and offers the advantage that the substrates for the ion exchange process mediated by the NCX can be controlled , suggesting that the observed inward currents are exclusively mediated by the NCX (Fig.3c) . 
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